Alcohol withdrawal syndromes in the intensive care unit

Crit Care Med. 2010 Sep;38(9 Suppl):S494-501. doi: 10.1097/CCM.0b013e3181ec5412.

Abstract

This article reviews the pathophysiology, diagnosis, and treatment of alcohol withdrawal syndromes in the intensive care unit as well as the literature on the optimal pharmacologic strategies for treatment of alcohol withdrawal syndromes in the critically ill. Treatment of alcohol withdrawal in the intensive care unit mirrors that of the general acute care wards and detoxification centers. In addition to adequate supportive care, benzodiazepines administered in a symptom-triggered fashion, guided by the Clinical Institute Withdrawal Assessment of Alcohol scale, revised (CIWA-Ar), still seem to be the optimal strategy in the intensive care unit. In cases of benzodiazepine resistance, numerous options are available, including high individual doses of benzodiazepines, barbiturates, and propofol. Intensivists should be familiar with the diagnosis and treatment strategies for alcohol withdrawal syndromes in the intensive care unit.

MeSH terms

  • Alcoholism / epidemiology
  • Central Nervous System Depressants / pharmacokinetics*
  • Critical Illness
  • Ethanol / pharmacokinetics*
  • Humans
  • Inactivation, Metabolic / physiology
  • Intensive Care Units*
  • Substance Withdrawal Syndrome* / diagnosis
  • Substance Withdrawal Syndrome* / drug therapy
  • Substance Withdrawal Syndrome* / physiopathology
  • United States / epidemiology

Substances

  • Central Nervous System Depressants
  • Ethanol